Intellia (NTLA) is a publicly traded Healthcare sector company. As of November 18, 2026, NTLA trades at $9.88 with a market cap of $1.38B and a P/E ratio of -3.62. NTLA moved -0.71% today. Year to date, NTLA is +4.54%; over the trailing twelve months it is +15.51%. Its 52-week range spans $5.90 to $28.25. Analyst consensus is neutral with an average price target of $19.20. Rallies surfaces NTLA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for NTLA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $9.88 |
| Market Cap | $1.38B |
| P/E Ratio | -3.62 |
| EPS | $-3.35 |
| Dividend Yield | 0.00% |
| 52-Week High | $28.25 |
| 52-Week Low | $5.90 |
| Volume | 5.93M |
| Avg Volume | 0 |
| Revenue (TTM) | $59.51M |
| Net Income | $-399.98M |
| Gross Margin | 0.00% |
11 analysts cover NTLA: 0 strong buy, 4 buy, 5 hold, 2 sell, 0 strong sell. Consensus rating is neutral. Average price target: $19.20.